Elanco Animal Health ELAN
NYSE ELAN
$23.88 -0.63 (-2.55%)
At close: Aug 20, 2026 · 11:55 AM UTC

Elanco Animal Health (ELAN) Total Non-Current Liabilities (2017 - 2026)

Elanco Animal Health (ELAN) posted Total Non-Current Liabilities of $6.3 billion for Q1 2026, down 3.87% sequentially from $6.5 billion in Q4 2025, and up 2.52% YoY from $6.1 billion in Q1 2025.

Elanco Animal Health (ELAN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Elanco Animal Health has reported Total Non-Current Liabilities for 10 years, with the latest figure at $6.3 billion in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 2.52% year-over-year to $6.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 billion (up 2.52% YoY) and the FY2025 annual result came in at $6.5 billion, up 4.68% from the prior year.
  • Total Non-Current Liabilities fell to $6.3 billion in Q1 2026 per ELAN's latest filing, from $6.5 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $8.4 billion in Q1 2022 and troughed at -$193.0 million in Q2 2022.
  • A 5-year average of $6.7 billion and a median of $7.4 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities sank 102.24% in 2022, then jumped 4226.94% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $8.0 billion in 2022, then declined by 3.07% to $7.7 billion in 2023, then decreased by 19.57% to $6.2 billion in 2024, then climbed by 4.68% to $6.5 billion in 2025, then dropped by 3.87% to $6.3 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $6.3 billion, $6.5 billion, and $6.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - 334.00 Mn
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn 2.45 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.42 Bn
Mar 31, 2026 6.26 Bn
Dec 31, 2025 6.51 Bn
Sep 30, 2025 6.20 Bn
Jun 30, 2025 6.33 Bn
Mar 31, 2025 6.10 Bn
Dec 31, 2024 6.22 Bn
Sep 30, 2024 6.17 Bn
Jun 30, 2024 7.36 Bn
Mar 31, 2024 7.49 Bn
Dec 31, 2023 7.73 Bn
Sep 30, 2023 7.78 Bn
Jun 30, 2023 7.97 Bn
Mar 31, 2023 8.04 Bn
Dec 31, 2022 7.97 Bn
Sep 30, 2022 7.98 Bn
Jun 30, 2022 -193.00 Mn
Mar 31, 2022 8.40 Bn
Dec 31, 2021 8.71 Bn
Sep 30, 2021 8.66 Bn